SYNALGOS-DC-A Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Synalgos-dc-a, and when can generic versions of Synalgos-dc-a launch?
Synalgos-dc-a is a drug marketed by Leitner Pharms and is included in one NDA.
The generic ingredient in SYNALGOS-DC-A is acetaminophen; caffeine; dihydrocodeine bitartrate. There are sixty-six drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the acetaminophen; caffeine; dihydrocodeine bitartrate profile page.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for SYNALGOS-DC-A?
- What are the global sales for SYNALGOS-DC-A?
- What is Average Wholesale Price for SYNALGOS-DC-A?
Summary for SYNALGOS-DC-A
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 3 |
| Patent Applications: | 12 |
| DailyMed Link: | SYNALGOS-DC-A at DailyMed |
US Patents and Regulatory Information for SYNALGOS-DC-A
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Leitner Pharms | SYNALGOS-DC-A | acetaminophen; caffeine; dihydrocodeine bitartrate | CAPSULE;ORAL | 089166-001 | May 14, 1986 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
